
ImmunoHorizons, Green Sunglasses, and Superheroes
Mark Kaplan, outgoing Editor-in-Chief of ImmunoHorizons, reflects on his time with the journal and where he sees open-access heading.
Mark Kaplan, outgoing Editor-in-Chief of ImmunoHorizons, reflects on his time with the journal and where he sees open-access heading.
AAI member, Deepta Bhattacharya, talks to us about the new Center for Advanced Molecular and Immunological Therapies (CAMI) at the University of Arizona.
AAI proudly announces the appointment of Bonnie N. Dittel, Ph.D., as the new editor-in-chief of ImmunoHorizons. Dr. Dittel’s five-year term will commence on January 1, 2025, and end on December 31, 2029.
Unlike legitimate society publishers, one of the red flags of a predatory publisher is insufficient communication with journal staff. Often, responses from predatory publishers leave you with more questions than answers.
Predatory publishers are finding creative ways to mimic legitimate author-outreach efforts. They are using language in their communications and on their websites that can be misleading to the untrained eye.